Clinical Trials Directory

Trials / Completed

CompletedNCT05708222

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)

Investigation of the Likelihood of a Current Major Depressive Episode in Individuals Referred to Sleep Clinics for Polysomnography (PSG) Assessment Using the MEB-001 Device.

Status
Completed
Phase
Study type
Observational
Enrollment
715 (actual)
Sponsor
Medibio Limited · Industry
Sex
All
Age
22 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to collect data to finalize the development of MEB-001 software as a medical device. The data collected in this study will be used to develop MEB-001 machine learning algorithms by training the algorithms to match the patient's demographic and clinical information, and the objective physiological signals (i.e., electroencephalogram (EEG) and electrocardiogram (ECG)) recorded during PSG with the diagnosis of cMDE performed through the MINI neuropsychiatric evaluation.

Detailed description

This is a two (2)-phase, single-arm, prospective, non-significant risk, multi-center trial where each enrolled subject's data will be used for the development of MEB-001. Study Population: Subjects who are at least 22 years old but not older than 75 years old, who have been referred to a sleep clinic for sleep disturbances and sign an informed consent form (ICF) will be evaluated for participation in this study. The selection of the population involved in the study will consider the geographic diversity needed to obtain a representative sample of the intended use population. Centers will be selected to secure geographic and clinical diversity across the USA to obtain a representative distribution of the intended patient population. All patients undergoing PSG due to primary or secondary sleep disorders, which include, but are not limited to, Sleep-Related Movement Disorders, Sleep-Related Breathing Disorders, Intrinsic and Extrinsic Circadian Rhythm Sleep-Wake Disorders, Hypersomnia, Parasomnia, and Insomnia, will be consecutively recruited, according to the inclusion/exclusion criteria.

Conditions

Interventions

TypeNameDescription
DEVICEMEB-001The study is for the development of a software medical device. The study participant will complete study specific questionnaires and undergo a routine sleep study. The medical device will not provide any treatment or interventions.

Timeline

Start date
2022-09-01
Primary completion
2024-07-09
Completion
2024-07-09
First posted
2023-02-01
Last updated
2024-07-11

Locations

13 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05708222. Inclusion in this directory is not an endorsement.